The impact of piperine on the metabolic conditions of patients with NAFLD and early cirrhosis: a randomized double-blind controlled trial.
- 2024-01-11
- RCT
- Scientific reports 14(1)
- Masoud Nouri-Vaskeh
- Payam Hashemi
- Naser Hataminia
- Yalda Yazdani
- Mahkameh Nasirian
- Leila Alizadeh
- PubMed: 38200253
- DOI: 10.1038/s41598-024-51726-z
- High evidence
- Rigorous Journal
- Clinical
Moreover, HOMA levels and insulin resistance were reduced in case participants compared to the control counterparts.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 5 mg/day